TobiasMartinHohlMD

Infectious Disease • New York, NY

Assistant Professor, Medicine, University of Washington School of Medicine

Join to view full profile

Dr. Hohl is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hohl's full profile

Already have an account?

Office
530 East 74th Street
New York, NY 10021

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Infectious Disease, 2003 - 2007
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2001 - 2003
Weill Cornell MedicineClass of 2001

Certifications & Licensure

NY State Medical License 2002 - 2026
WA State Medical License 2008 - 2015
American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

GM-CSF-mediated epithelial-immune cell cross-talk orchestrates pulmonary immunity to.
Kathleen A M Mills, Frederike Westermann, Vanessa Espinosa, Eric Rosiek, Jigar V Desai
Science Immunology. 2025-03-21
Evaluating the clinical utility of,andbronchoalveolar PCRs for the diagnosis of invasive pulmonary infections in patients with hematological malignancies.
Varshini Gali, Rakan Al-Ghanamah, Katie Finnigan, Or Kalchiem-Dekel, Mini Kamboj
Journal of Clinical Microbiology. 2025-02-19
Perforin-2 is dispensable for host defense againstand.
Mariano A Aufiero, Li-Yin Hung, De'Broski R Herbert, Tobias M Hohl
Msphere. 2025-01-28

Journal Articles

Response to Comment on “Sterilizing Immunity in the Lung Relies on Targeting Fungal Apoptosis-like Programmed Cell Death”
Tobias Hohl, MD, Science Magazine

Press Mentions

Cancer Patients May Be at Greater Risk of Death from COVID-19October 4th, 2022
Dangerous Fungal Lung Infections Could Be Treated with CAR T-cellsSeptember 28th, 2022
Antibiotics Induce Invasive Candidiasis in Mice and Humans, Immunotherapy Could HelpMay 16th, 2022
Join now to see all

Grant Support

Fungal Pathogenicity Determinants through the Lens of Immune-Targeted Cancer TherapiesDARTMOUTH COLLEGE2025–2030
Understanding the molecular mechanisms regulating fungal colonization and disease in the mammalian intestinal nicheSLOAN-KETTERING INST CAN RESEARCH2024–2029
INITIATION OF THE IMMUNE RESPONSE TO ASPERGILLUS FUMIGATUSSLOAN-KETTERING INST CAN RESEARCH2011–2026
INITIATION OF THE IMMUNE RESPONSE TO ASPERGILLUS FUMIGATUSSLOAN-KETTERING INST CAN RESEARCH2011–2026
INITIATION OF THE IMMUNE RESPONSE TO ASPERGILLUS FUMIGATUSSLOAN-KETTERING INST CAN RESEARCH2011–2026
INITIATION OF THE IMMUNE RESPONSE TO ASPERGILLUS FUMIGATUSSLOAN-KETTERING INST CAN RESEARCH2011–2026
2025 Immunology of Fungal Infections Gordon Research Conference and Gordon Research SeminarGORDON RESEARCH CONFERENCES2024–2025
2025 Immunology of Fungal Infections Gordon Research Conference and Gordon Research SeminarGORDON RESEARCH CONFERENCES2024–2025
2025 Immunology of Fungal Infections Gordon Research Conference and Gordon Research SeminarGORDON RESEARCH CONFERENCES2024–2025
2025 Immunology of Fungal Infections Gordon Research Conference and Gordon Research SeminarGORDON RESEARCH CONFERENCES2024–2025
Antifungal Immunity and the Mechanism of Fungal Programmed Cell DeathSLOAN-KETTERING INST CAN RESEARCH2019–2024
Initiation Of The Immune Response To Aspergillus FumigatusNational Institute Of Allergy And Infectious Diseases2011
Monocyte-Mediated Host Defense Against Aspergillus FumigatusNational Institute Of Allergy And Infectious Diseases2009–2010
Monocyte-Mediated Host Defense Against Aspergillus FumigatusNational Institute Of Allergy And Infectious Diseases2008–2009